EPO Patents = 1

Trademarks = 12

Forward Citations = 12

Loading Chart...

11 inventors (with patents filed for the assignee):

Mark Mitchnick (7 out of 45 patents)

Steve Cartt (7 out of 15 patents)

David Medeiros (7 out of 10 patents)

4. Garry Thomas Gwozdz (7 out of 25 patents)

5. David F Hale (6 out of 13 patents)

6. Edward T Maggio (6 out of 53 patents)

7. Andrew Loxley (5 out of 5 patents)

8. Andrew L Loxley (2 out of 54 patents)

9. Stuart Madden (1 out of 1 patent)

10. Adrian L Rabinowicz (1 out of 1 patent)

11. Enrique J Carrazana (1 out of 1 patent)

9 patents: Sort by Forward Citations

1. 12758561 - Administration of benzodiazepine compositions (2026-10-13),

2. 12599611 - Methods and compositions for treating seizure disorders in pediatric patients (2026-04-14),

3. 12521400 - Administration of benzodiazepine compositions (2026-01-13),

4. 12337061 - Administration of benzodiazepine compositions (2025-06-24),

5. 12324852 - Administration of benzodiazepine compositions (2025-06-10),

6. 12268664 - Administration of benzodiazepine compositions (2025-04-08),

7. 12171868 - Intranasal olanzapine formulations and methods of their use (2024-12-24),

8. 11793786 - Administration of benzodiazepine compositions (2023-10-24),

9. 11241414 - Administration of benzodiazepine compositions (2022-02-08),

Company Overview

Neurelis, Inc. is a biopharmaceutical company focused on developing innovative therapies for the treatment of central nervous system disorders. The company aims to address unmet medical needs through its proprietary drug delivery technologies and formulations. Neurelis is committed to improving the lives of patients by providing effective and safe treatment options. Their lead product candidate is designed to offer rapid and effective relief for patients experiencing seizures. With a strong emphasis on research and development, Neurelis collaborates with healthcare professionals and researchers to advance its pipeline and bring new therapies to market.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

9 Patents

#580 in San Diego, CA

#7,745 in California

#32,605 in US

San Diego, CA, United States of America

Neurelis, Inc.

Forward Citations = 12

11 inventors:

Mark Mitchnick (7 out of 45 patents)

Steve Cartt (7 out of 15 patents)

David Medeiros (7 out of 10 patents)

4. Garry Thomas Gwozdz (7 out of 25 patents)

5. David F Hale (6 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Neurelis, Inc.. Retrieved from https://idiyas.com/company/neurelis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]